Drugs / Trolamine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial · 1 missed | ||||||
| Phase 3 | NCT00006481 | Oct 2000 → Aug 2002 | head and neck squamous cell carcinoma, radiodermatitis | Radiation Therapy Oncology Group | Completed | Missed primary |
| Phase 41 trial | ||||||
| Phase 4 | NCT07492654 | Mar 2026 → Dec 2030 expected | mucositis, vaginitis | Fujian Cancer Hospital | Not yet recruiting | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT02729324 Comparator | Apr 2016 → Jun 2017 | nasopharyngeal neoplasm, radiodermatitis | Yun-fei Xia | Unknown | No outcome recorded |
| — | NCT06484166 Comparator | Aug 2024 → Mar 2025 | radiodermatitis | West China Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trolamine | “PURPOSE: This multicentered phase III trial was designed to compare an emulsion containing trolamine against the usual supportive care within each participating institution for...” PMID 16648511 ↗ May 2006 |
| Known as | Biafine | “Trolamine (Biafine) is prescribed at the beginning of radiotherapy.” NCT02729324 ↗1“Drug: Trolamine (Biafine)” NCT07492654 ↗ |
| Route | Topical | “with Biafine cream applied to skin 3 times daily 7 days a week” NCT00006481 ↗ |